Literature DB >> 17394300

Development of molecular probes for second-site screening and design of protein tyrosine phosphatase inhibitors.

Jesus Vazquez1, Lutz Tautz, Jennifer J Ryan, Kristiina Vuori, Tomas Mustelin, Maurizio Pellecchia.   

Abstract

We report on the design, synthesis, and evaluation of a series of furanyl-salicyl-nitroxide derivatives as effective chemical probes for second-site screening against phosphotyrosine phosphatases (PTPs) using NMR-based techniques. The compounds have been tested against a panel of PTPs to assess their ability to inhibit a broad spectrum of these phosphatases. The utility of the derived compounds is illustrated with the phosphatase YopH, a bacterial toxin from Yersinia pestis. Novel chemical fragments were identified during an NMR-based screen for compounds that are capable of binding on the surface of YopH in regions adjacent the catalytic site in the presence of the spin-labeled compounds. Our data demonstrate the value of the derived chemical probes for NMR-based second-site screening in PTPs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17394300      PMCID: PMC2615387          DOI: 10.1021/jm061481l

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  18 in total

Review 1.  NMR-based techniques in the hit identification and optimisation processes.

Authors:  Maurizio Pellecchia; Barbara Becattini; Kevin J Crowell; Roberto Fattorusso; Martino Forino; Marco Fragai; Dawoon Jung; Tomas Mustelin; Lutz Tautz
Journal:  Expert Opin Ther Targets       Date:  2004-12       Impact factor: 6.902

Review 2.  Discovering new drug-targeting sites on flexible multidomain protein kinases: Combining segmental isotopic and site-directed spin labeling for nuclear magnetic resonance detection of interfacial clefts.

Authors:  Thomas K Harris
Journal:  Methods Mol Biol       Date:  2006

3.  Inhibition of Yersinia tyrosine phosphatase by furanyl salicylate compounds.

Authors:  Lutz Tautz; Shane Bruckner; Sina Sareth; Andres Alonso; Jori Bogetz; Nunzio Bottini; Maurizio Pellecchia; Tomas Mustelin
Journal:  J Biol Chem       Date:  2004-12-22       Impact factor: 5.157

4.  Discovering high-affinity ligands for proteins: SAR by NMR.

Authors:  S B Shuker; P J Hajduk; R P Meadows; S W Fesik
Journal:  Science       Date:  1996-11-29       Impact factor: 47.728

5.  Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy.

Authors:  Bruce G Szczepankiewicz; Gang Liu; Philip J Hajduk; Cele Abad-Zapatero; Zhonghua Pei; Zhili Xin; Thomas H Lubben; James M Trevillyan; Michael A Stashko; Stephen J Ballaron; Heng Liang; Flora Huang; Charles W Hutchins; Stephen W Fesik; Michael R Jirousek
Journal:  J Am Chem Soc       Date:  2003-04-09       Impact factor: 15.419

Review 6.  Protein tyrosine phosphatases and their inhibitors.

Authors:  Purushottam M Dewang; Nai-Mu Hsu; Shao-Zheng Peng; Wen-Ren Li
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

Review 7.  Spin labels as a tool to identify and characterize protein-ligand interactions by NMR spectroscopy.

Authors:  Wolfgang Jahnke
Journal:  Chembiochem       Date:  2002-03-01       Impact factor: 3.164

8.  Targeting apoptosis via chemical design: inhibition of bid-induced cell death by small organic molecules.

Authors:  Barbara Becattini; Sina Sareth; Dayong Zhai; Kevin J Crowell; Marilisa Leone; John C Reed; Maurizio Pellecchia
Journal:  Chem Biol       Date:  2004-08

9.  Tyrosine phosphorylation of VHR phosphatase by ZAP-70.

Authors:  Andres Alonso; Souad Rahmouni; Scott Williams; Marianne van Stipdonk; Lukasz Jaroszewski; Adam Godzik; Robert T Abraham; Stephen P Schoenberger; Tomas Mustelin
Journal:  Nat Immunol       Date:  2002-11-25       Impact factor: 25.606

10.  Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions.

Authors:  M Piotto; V Saudek; V Sklenár
Journal:  J Biomol NMR       Date:  1992-11       Impact factor: 2.835

View more
  9 in total

1.  NMR-based design and evaluation of novel bidentate inhibitors of the protein tyrosine phosphatase YopH.

Authors:  Marilisa Leone; Elisa Barile; Jesus Vazquez; Angel Mei; Donald Guiney; Russel Dahl; Maurizio Pellecchia
Journal:  Chem Biol Drug Des       Date:  2010-04-28       Impact factor: 2.817

2.  Development of paramagnetic probes for molecular recognition studies in protein kinases.

Authors:  Jesus Vazquez; Surya K De; Li-Hsing Chen; Megan Riel-Mehan; Aras Emdadi; Jason Cellitti; John L Stebbins; Michele F Rega; Maurizio Pellecchia
Journal:  J Med Chem       Date:  2008-06-26       Impact factor: 7.446

3.  Design and NMR studies of cyclic peptides targeting the N-terminal domain of the protein tyrosine phosphatase YopH.

Authors:  Marilisa Leone; Elisa Barile; Russell Dahl; Maurizio Pellecchia
Journal:  Chem Biol Drug Des       Date:  2010-11-30       Impact factor: 2.817

4.  A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptors.

Authors:  Roberta Noberini; Surya K De; Ziming Zhang; Bainan Wu; Dhanya Raveendra-Panickar; Vida Chen; Jesus Vazquez; Haina Qin; Jianxing Song; Nicholas D P Cosford; Maurizio Pellecchia; Elena B Pasquale
Journal:  Chem Biol Drug Des       Date:  2011-09-06       Impact factor: 2.817

Review 5.  Perspectives on NMR in drug discovery: a technique comes of age.

Authors:  Maurizio Pellecchia; Ivano Bertini; David Cowburn; Claudio Dalvit; Ernest Giralt; Wolfgang Jahnke; Thomas L James; Steve W Homans; Horst Kessler; Claudio Luchinat; Bernd Meyer; Hartmut Oschkinat; Jeff Peng; Harald Schwalbe; Gregg Siegal
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

6.  High-Throughput Screening (HTS) by NMR Guided Identification of Novel Agents Targeting the Protein Docking Domain of YopH.

Authors:  Angel Bottini; Bainan Wu; Elisa Barile; Surya K De; Marilisa Leone; Maurizio Pellecchia
Journal:  ChemMedChem       Date:  2015-11-23       Impact factor: 3.466

Review 7.  Fragment-based drug discovery using NMR spectroscopy.

Authors:  Mary J Harner; Andreas O Frank; Stephen W Fesik
Journal:  J Biomol NMR       Date:  2013-05-18       Impact factor: 2.835

8.  Perspectives of biomolecular NMR in drug discovery: the blessing and curse of versatility.

Authors:  Wolfgang Jahnke
Journal:  J Biomol NMR       Date:  2007-08-15       Impact factor: 2.582

Review 9.  NMR-based approaches for the identification and optimization of inhibitors of protein-protein interactions.

Authors:  Elisa Barile; Maurizio Pellecchia
Journal:  Chem Rev       Date:  2014-04-08       Impact factor: 60.622

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.